NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - NKGen Biotech ( NASDAQ:NKGN )

2 weeks ago

SANTA ANA, Calif., Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- NKGen Biotech, Inc. NKGN ( "NKGen" or the "Company" ) , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer ( "NK" ) cell therapeutics, today ...

Ticker	Sentiment	Impact
NKGN	Neutral	11 %